Position in ERAS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,326,000
New position
Shares Held
700,000
first reported quarter
Ownership
0.225%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Integral Health Asset Management, LLC holds $1,255,592,830 across 56 Biotechnology names. ERAS ranks #25 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,500,000 | $245,280,000 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,500,000 | $145,875,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,600,000 | $105,456,000 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,000 | $65,674,400 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
1,600,000 | $64,368,000 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
2,000,000 | $55,400,000 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
600,000 | $52,182,000 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
1,600,000 | $50,400,000 |
All Filings in ERAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,326,000 | 700,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||